Mild Cognitive Impairment (MCI) is an early stage of memory or other cognitive ability loss, and it is easily confused with normal aging due to the subtle changes. People living with MCI are potentially at higher risk of developing dementia, including Alzheimer’s disease. Studies estimate that 15% to 20% of individuals with MCI go on to develop dementia each year. Early detection of MCI is critical for future treatment and care.

HippoScreen's Brain Degeneration Risk (BDR) Assessment System developed using MCI EEG data collected through collaboration with four major medical centers in Taiwan, includes an EEG amplifier for data collection and signal processing, a GUI for test process control, and an AI algorithm for data analysis. It records 2-minute brainwave signals to analyze with an AI algorithm and then provides objective and quantifiable assessment results. BDR Assessment System is designed to be a powerful AI tool for professional medical personnel in brain health screening.